+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review

FEATURED COMPANIES

  • Insys Therapeutics Inc
  • Nektar Therapeutics
  • Purdue Pharma LP
  • Sentynl Therapeutics Inc
  • Theravance Biopharma Inc
  • MORE
BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company that develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.

BioDelivery Sciences International Inc Key Recent Developments

May 11, 2020: BioDelivery Sciences appoints Jeff Bailey interim CEO
May 07, 2020: BioDelivery Sciences reports strong Q1 2020 results
Mar 12, 2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
Mar 09, 2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
Jan 13, 2020: BioDelivery Sciences expects fourth quarter and 2019 total net sales at the high end of guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Insys Therapeutics Inc
  • Nektar Therapeutics
  • Purdue Pharma LP
  • Sentynl Therapeutics Inc
  • Theravance Biopharma Inc
  • MORE
Section 1 - About the Company
  • BioDelivery Sciences International Inc - Key Facts
  • BioDelivery Sciences International Inc - Key Employees
  • BioDelivery Sciences International Inc - Key Employee Biographies
  • BioDelivery Sciences International Inc - Major Products and Services
  • BioDelivery Sciences International Inc - History
  • BioDelivery Sciences International Inc - Company Statement
  • BioDelivery Sciences International Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • BioDelivery Sciences International Inc - Business Description
  • Business Segment: Contract Revenue
  • Overview
  • Performance
  • Business Segment: Product Royalty Revenue
  • Overview
  • Performance
  • Business Segment: Product Sales
  • Overview
  • Performance
  • Business Segment: Research and Development Reimbursements
  • Performance
  • BioDelivery Sciences International Inc - Corporate Strategy
  • BioDelivery Sciences International Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • BioDelivery Sciences International Inc - Strengths
  • BioDelivery Sciences International Inc - Weaknesses
  • BioDelivery Sciences International Inc - Opportunities
  • BioDelivery Sciences International Inc - Threats
  • BioDelivery Sciences International Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • BioDelivery Sciences International Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 11, 2020: BioDelivery Sciences appoints Jeff Bailey interim CEO
  • May 07, 2020: BioDelivery Sciences reports strong Q1 2020 results
  • Mar 12, 2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
  • Mar 09, 2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
  • Jan 13, 2020: BioDelivery Sciences expects fourth quarter and 2019 total net sales at the high end of guidance
  • Jan 06, 2020: BioDelivery Sciences appoints Kevin Ostrander as Senior Vice President of Business Development
  • Dec 19, 2019: BioDelivery Sciences added to NASDAQ Biotechnology Index
  • Nov 25, 2019: BioDelivery Sciences appoints Dr. Vanila Singh, former Chief Medical Officer of Health and Human Services, to its Board of Directors
  • Nov 12, 2019: BioDelivery Sciences reports strong third quarter results, raises full year 2019 and provides 2020 net sales expectations
  • Aug 08, 2019: BioDelivery Sciences reports strong second quarter 2019 results and raises net sales expectations
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • BioDelivery Sciences International Inc, Key Facts
  • BioDelivery Sciences International Inc, Key Employees
  • BioDelivery Sciences International Inc, Key Employee Biographies
  • BioDelivery Sciences International Inc, Major Products and Services
  • BioDelivery Sciences International Inc, History
  • BioDelivery Sciences International Inc, Subsidiaries
  • BioDelivery Sciences International Inc, Key Competitors
  • BioDelivery Sciences International Inc, Ratios based on current share price
  • BioDelivery Sciences International Inc, Annual Ratios
  • BioDelivery Sciences International Inc, Annual Ratios
  • BioDelivery Sciences International Inc, Interim Ratios
  • BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • BioDelivery Sciences International Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • BioDelivery Sciences International Inc, Performance Chart (2015 - 2019)
  • BioDelivery Sciences International Inc, Ratio Charts
  • BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Theravance Biopharma Inc
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Co Ltd
  • Synergy Pharmaceuticals Inc
  • Sentynl Therapeutics Inc
  • Purdue Pharma LP
  • Progenics Pharmaceuticals Inc
  • Nektar Therapeutics
  • Ironwood Pharmaceuticals Inc
  • Insys Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll